CIRTRAN CORP 10-Q

ITEM 1. FINANCIAL STATEMENTS CIRTRAN CORPORATION CONSOLIDATED BALANCE SHEETS September 30, 2022 December 31, 2021 (Unaudited) (Audited) ASSETS Current assets: Cash $ 40,549 $ 5,472 Inventory 727,701 537,961 Deposits on inventory 45,280 11,639 Deposits on inventory - related party 272,597 87,042 Accounts receivable 83,301 212,244 Other current assets 267,780 267,820 Total current assets 1,437,208 1,122,178 Investment in securities at cost 300,000 300,000 Right-of-use asset — 22,291 Property and equipment, net of accumulated depreciation 16,042 18,899 Total assets $ 1,753,250 $ 1,463,368 LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities: Accounts payable $ 2,036,860 $ 1,923,968 Lease liability, current — 22,291 Related-party payable 13,740 13,740 Short-term advances payable 43,366 58,366 Short-term advances payable - related parties 21,882 21,882 Accrued liabilities 1,870,241 1,338,349 Accrued payroll and compensation expense 4,724,025 4,441,398 Accrued interest, current portion 5,150,408 4,880,219 Convertible debenture, current portion, net of discounts 264,284 264,284 Note payable, current portion 90,000 90,000 Note payable to stockholders 182,129 313,274 Derivative liability 973,902 938,794 Liabilities from discontinued operations 25,303,919 25,189,136 Total current liabilities: 40,674,756 39,495,701 Note payable, net of current portion 656,000 656,000 Convertible debenture, net of current portion, net of discount 1,944,778 1,876,621 Total liabilities 43,275,534 42,028,322 Commitments and contingencies — — Stockholders’ deficit: Common stock, par value $ 0.001 ; 100,000,000 shares authorized; 4,945,417 shares issued and outstanding 4,945 4,945 Additional paid-in capital 37,233,561 37,233,561 Accumulated deficit ( 78,760,790 ) ( 77,803,460 ) Total stockholders’ deficit ( 41,522,284 ) ( 40,564,954 ) Total liabilities and stockholders’ deficit $ 1,753,250 $ 1,463,368 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 3 CIRTRAN CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 2022 2021 2022 2021 Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Net sales $ 477,018 $ 961,474 $ 1,695,707 $ 2,281,529 Cost of sales 170,108 339,076 580,961 803,135 Gross profit 306,910 622,398 1,114,746 1,478,394 Operating expenses Employee costs 139,751 139,520 406,751 408,485 Selling, general and administrative expenses 293,891 514,358 987,662 1,165,870 Total operating expenses 433,642 653,878 1,394,413 1,574,355 Loss from operations ( 126,732 ) ( 31,480 ) ( 279,667 ) ( 95,961 ) Other expense: Interest expense ( 179,342 ) ( 172,400 ) ( 527,774 ) ( 507,614 ) Gain on forgiveness of debt — — — 12,917 Loss on derivative valuation ( 1,156 ) ( 62,086 ) ( 35,105 ) ( 176,746 ) Total other expense ( 180,498 ) ( 234,486 ) ( 562,879 ) ( 671,443 ) Net loss from continuing operations ( 307,230 ) ( 265,966 ) ( 842,546 ) ( 767,404 ) Loss from discontinued operations ( 38,682 ) ( 38,682 ) ( 114,784 ) ( 114,784 ) Net loss $ ( 345,912 ) $ ( 304,648 ) $ ( 957,330 ) $ ( 882,188 ) Net loss from continuing operations per common share, basic and diluted $ ( 0.06 ) $ ( 0.06 ) $ ( 0.17 ) $ ( 0.16 ) Net loss from discontinued operations per common share, basic and diluted $ ( 0.01 ) $ ( 0.01 ) $ ( 0.02 ) $ ( 0.02 ) Net loss per common share, basic and diluted $ ( 0.07 ) $ ( 0.07 ) $ ( 0.19 ) $ ( 0.18 ) Basic and diluted weighted average common shares outstanding 4,945,417 4,945,417 4,945,417 4,872,890 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 4 CIRTRAN CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021 (Unaudited) Shares Amount Capital Deficit Deficit Common Stock Additional Paid-in Accumulated Total Stockholders’ Shares Amount Capital Deficit Deficit Balance, December 31, 2021 4,945,417 $ 4,945 $ 37,233,561 $ ( 77,803,460 ) $ ( 40,564,954 ) Net loss — — — ( 296,503 ) ( 296,503 ) Balance, March 31, 2022 4,945,417 4,945 37,233,561 ( 78,099,963 ) ( 40,861,457 ) Net loss — — — ( 314,915 ) ( 314,915 ) Balance, June 30, 2022 4,945,417 4,945 37,233,561 ( 78,414,878 ) ( 41,176,372 ) Net loss — — — ( 345,912 ) ( 345,912 ) Balance, September 30, 2022 4,945,417 $ 4,945 $ 37,233,561 $ ( 78,760,790 ) $ ( 41,522,284 ) Common Stock Additional Paid-in Accumulated Total Stockholders’ Shares Amount Capital Deficit Deficit Balance, December 31, 2020 4,720,417 $ 4,720 $ 37,226,851 $ ( 77,929,672 ) $ ( 40,698,101 ) Common stock issued for conversion of accrued interest 225,000 225 6,525 — 6,750 Net loss — — — ( 327,555 ) ( 327,555 ) Balance, March 31, 2021 4,945,417 4,945 37,233,376 ( 78,257,227 ) ( 41,018,906 ) Net loss — — — ( 249,985 ) ( 249,985 ) Balance, June 30, 2021 4,945,417 4,945 37,233,376 ( 78,507,212 ) ( 41,268,891 ) Net loss — — — ( 304,648 ) ( 304,648 ) Balance, September 30, 2021 4,945,417 $ 4,945 $ 37,233,376 $ ( 78,811,860 ) $ ( 41,573,539 ) The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 5 CIRTRAN CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) 2022 2021 For the Nine Months Ended September 30, 2022 2021 Cash flows from operating activities Net loss $ ( 957,330 ) $ ( 882,188 ) Adjustments to reconcile net income to net cash (used) provided by operating activities: Loss from discontinued operations 114,784 114,784 Depreciation expense 2,857 2,389 Loss on derivative valuation 35,105 176,746 Debt discount amortization 68,157 66,389 Gain on forgiveness of debt — ( 12,917 ) Amortization of right-of-use asset to rent expense 22,291 21,224 Expenses paid on our behalf by a related party — ( 268,924 ) Changes in operating assets and liabilities: Inventory ( 189,740 ) ( 169,538 ) Deposits on inventory ( 33,641 ) 43,011 Deposits on inventory - related party ( 185,555 ) 90,603 Accounts receivable 128,943 ( 147,421 ) Other current assets 40 ( 155,091 ) Accounts payable 112,892 499,753 Accrued liabilities 608,019 58,711 Payments for lease liability ( 22,291 ) ( 21,224 ) Accrued payroll and compensation 193,310 294,824 Accrued interest 270,189 441,222 Net cash provided by operating activities 168,030 152,353 Cash flows from investing activities: Purchase of equipment — ( 1,624 ) Net cash used in investing activities — ( 1,624 ) Cash flows from financing activities: Proceeds from related-party loans 6,930 — Repayments of related-party loans ( 139,883 ) ( 214,421 ) Net cash used by financing activities ( 132,953 ) ( 214,421 ) Net change in cash 35,077 ( 63,692 ) Cash, beginning of period 5,472 108,147 Cash, end of period $ 40,549 $ 44,455 Supplemental disclosure of cash flow information: Cash paid for interest $ — $ — Cash paid for income taxes $ — $ — Supplemental disclosure of noncash investing activities: Common stock issued for conversion of accrued interest $ — $ 6,750 The accompanying notes are an integral part of these unaudited condensed financial statements. 6 CIRTRAN CORPORATION NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2022 NOTE 1 — ORGANIZATION AND NATURE OF OPERATIONS In 1987, CirTran Corporation was incorporated in Nevada under the name Vermillion Ventures, Inc., for the purpose of acquiring other operating corporate entities. We were largely inactive until July 1, 2000, when our wholly owned subsidiary, CirTran Corporation (Utah), acquired substantially all the assets and certain liabilities of Circuit Technology, Inc., founded by our president, Iehab Hawatmeh. We, together with our majority-owned subsidiaries, manufacture, distribute, and sell condoms, electronic tobacco products, cigars, energy drinks, water beverages, and related merchandise, all using the HUSTLER® brand name. Since entering our 2019 five-year manufacturing and distribution agreement with an unrelated party, our efforts have been devoted to phase one of our development of all HUSTLER®-branded products, which led us to generating revenue during 2020 for the first time in several years. NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation Our unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). These financial statements and the notes attached hereto should be read in conjunction with the financial statements and notes included in our Form 10-K for the fiscal year ended December 31, 2021. In the opinion of our management, all adjustments, including normal recurring adjustments necessary to present fairly our financial position, as of September 30, 2022, and the results of our operations and cash flows for the nine months then ended have been included. The results of operations for the interim period are not necessarily indicative of the results for the full year ending December 31, 2022. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates. Principles of Consolidation The consolidated financial statements include the accounts of the company and our wholly owned subsidiaries: CirTran Products Corp., LBC Products, Inc., and CirTran Asia, Inc. All intercompany accounts and transactions have been eliminated in consolidation Revenue Recognition We follow Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers , for revenue recognition. Adoption of ASC 606 did not have a significant impact on our financial statements. We generate revenue by providing product design services and through the sales of tangible product. We recognize revenue upon transfer of control of promised products or services to customers in an amount that reflects the consideration expected to be received in exchange for those products or services. We determine the transaction price associated with each deliverable based on the unique contract with the customer, which is a stand-alone contract that we retain the right to accept or reject. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities. 7 During the nine months ended September 30, 2022 and 2021, we recognized revenue of $ 402,723 and $ 30,000 , respectively, and $ 175,319 and $ 0 , during the three months ended September 30, 2022 and 2021, respectively, related to the performance obligations under product development service agreements with customers. These contracts are long term in nature and revenue is recognized at certain milestone intervals upon our delivery and customer acceptance of work product related to those milestones: namely, product design, packaging, branding display, and prototypes. There were no costs to obtain the contracts identified, and therefore, no asset has been recorded for customer acquisition costs. Additionally, we recognized revenue of $ 1,292,984 and $ 2,281,529 during the nine months ended September 30, 2022 and 2021, respectively, and $ 301,699 and $ 961,074 , during the three months ended September 30, 2022 and 2021, respectively, related to the delivery of product to our customers. Each delivery is based on the unique contract with the customer, which is a stand-alone contract that we retain the right to accept or reject. Upon acceptance, we oblige delivery of such product to the customer at an agreed-upon place, time, and price. We recognize revenue under the unique contract upon fulfilment of our performance obligations therein, typically limited to the delivery of product. Leases In February 2016, the FASB issued Accounting Standard Update (“ASU”) 2016-02, Leases (Topic 842), which superseded guidance in ASC 840, Leases , which we adopted for the year ended December 31, 2019, under the modified retrospective transition approach by applying the new standard to all leases existing at the date of initial application. We account for short-term leases, those lasting fewer than 12 months, using the practical expedient as outlined in the guidance, which does not include recording such leases on the balance sheet. The adoption of the standard resulted in recording right-of-use (“ROU”) assets and operating lease liabilities of $ 22,291 as of December 31, 2021. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As the lease does not provide an implicit rate, we use our incremental borrowing rate based on information available at the commencement date in determining the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Lease terms may include options to extend or terminate the lease when it is reasonably certain we will exercise that option. Although considered, we determined it was appropriate to exclude future renewal terms from the capitalization of our operating lease. We have one lease in effect requiring minimum monthly payments of $ 2,500 through October 2022. We have determined the appropriate discount rate to be 5 % based on our other borrowings secured by assets. The lease was renewed on October 19, 2022, on a month to months basis, with payments remaining at $ 2,500 a month. Investment in Securities Our cost-method investment consists of an investment in a private digital multi-media technology company that totaled $ 300,000 at September 30, 2022, and December 31, 2021. Because we owned less than 20 % of that company’s stock as of each date, and no significant influence or control exists, the investment is accounted for using the cost method. We evaluated the investment for impairment and determined there was none during the periods presented. Inventories Inventories are stated at the lower of average cost or net realizable value. Cost on manufactured inventories includes labor, material, and overhead. Overhead cost is based on indirect costs allocated to cost of sales, work-in-process inventory, and finished goods inventory. Indirect overhead costs have been charged to cost of sales or capitalized as inventory, based on management’s estimate of the benefit of indirect manufacturing costs to the manufacturing process. When there is evidence that the inventory’s value is less than original cost, the inventory is reduced to market value. We determine market value on current resale amounts and whether technological obsolescence exists. We will seek agreements with manufacturing customers that require them to purchase their inventory items in the event they cancel their business with us. 8 From time to time, we will place deposits on inventory to be delivered in the future. These deposits are carried as a separate balance sheet component and totaled $ 45,280 (non-related-party) and $ 272,597 (related-party) as of September 30, 2022, and $ 11,639 (non-related-party) and $ 87,042 (related-party) as of December 31, 2021. Inventory balances consisted of the following: SCHEDULE OF INVENTORY September 30, 2022 December 31, 2021 Finished goods $ 699,124 $ 501,929 Raw materials 28,577 36,032 Total $ 727,701 $ 537,961 Fair Value of Financial Instruments ASC 820-10-15, Fair Value Measurement-Overall-Scope and Scope Exceptions , defines fair value, thereby eliminating inconsistencies in guidance found in various prior accounting pronouncements, and increases disclosures surrounding fair value calculations. ASC 820-10-15 establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations. The three levels of inputs are defined as follows: Level 1 —Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 —Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 —Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. Accounts payable and related-party payables have fair values that approximate the carrying value due to the short-term nature of these instruments. Derivative liabilities are measured using level 3 inputs. SCHEDULE OF FINANCIAL ASSETS AND LIABILITIES CARRIED AT FAIR VALUED MEASURED ON RECURRING BASIS Total Fair Value at September 30, 2022 Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Derivative liabilities $ 973,902 $ - $ - $ 973,902 Total Fair Value at December 31, 2021 Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Derivative liabilities $ 938,794 $ - $ - $ 938,794 Loss per Share Basic loss per share is calculated by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during each period. Diluted loss per share is similarly calculated, except that the weighted-average number of common shares outstanding would include common shares that may be issued subject to existing rights with dilutive potential when applicable. There were 106,038,406 potentially issuable shares from the conversions of convertible debentures outstanding that were excluded in dilutive outstanding shares as of September 30, 2022, due to the anti-dilutive effect these would have on net loss per share. There were 141,554,300 such shares issuable as of September 30, 2021. We do not currently have adequate authorized but unissued shares to satisfy our obligations should all instruments eligible to convert to common stock be exercised. We are not currently contemplating an increase in our authorized shares but may do so in the future. 9 Recently Issued Accounting Pronouncements We have implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on our financial statements unless otherwise disclosed, and we do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations. NOTE 3 — GOING CONCERN The accompanying unaudited consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplate our continuation as a going concern. We had a working capital deficiency of $ 39,237,548 as of September 30, 2022, and a net loss from continuing operations of $ 842,546 for the nine months ended September 30, 2022. As of September 30, 2022, we had an accumulated deficit of $ 78,760,790 . These conditions raise substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon our ability to successfully accomplish our business plan and eventually attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if we are unable to continue as a going concern. In the coming year, our foreseeable cash requirements will relate to development of business operations and associated expenses. We may experience a cash shortfall and be required to raise additional capital. Historically, we have mainly relied upon shareholder loans and advances to finance operations and growth. Management may raise additional capital by retaining net earnings, if any, or through future public or private offerings of our stock or loans from private investors, although we cannot assure that we will be able to obtain such financing. Our failure to do so could have a material and adverse effect upon our shareholders and us. NOTE 4 — PROPERTY AND EQUIPMENT We incur certain costs associated with the design and development of molds and dies for our contract-manufacturing segment. These costs are held as deposits on the balance sheet until the molds or dies are finished and ready for use. At that point, the costs are included as part of production equipment in property and equipment and are amortized over their useful lives. We hold title to all molds and dies used in the manufacture of products. Property and equipment and estimated service lives consist of the following: SCHEDULE OF PROPERTY AND EQUIPMENT AND ESTIMATED SERVICE LIVES September 30, 2022 December 31, 2021 Useful Life (years) Furniture and office equipment $ 3,798 $ 3,798 5 - 10 Vehicles 18,672 18,672 3 - 7 Total 22,470 22,470 Less: accumulated depreciation ( 6,428 ) ( 3,571 ) Property and equipment, net $ 16,042 $ 18,899 We recorded $ 2,857 and $ 2,389 depreciation expense for the nine months ended September 30, 2022 and 2021. NOTE 5 — RELATED PARTY TRANSACTIONS In 2007, we issued a 10 % promissory note to a family member of our president in exchange for $ 300,000 . The note was due on demand after May 2008. There were no repayments made during the periods presented. At September 30, 2022, and December 31, 2021, the principal amount owing on the note was $ 151,833 and $ 151,833 , respectively. No demand for payment has been made. 10 On March 31, 2008, we issued to this same family member, along with two other company shareholders, promissory notes totaling $ 315,000 ($ 105,000 each). Under the terms of these three $ 105,000 notes, we received total proceeds of $ 300,000 and agreed to repay the amount received plus a 5 % borrowing fee. The notes were due April 30, 2008, after which they were due on demand, with interest accruing at 12 % per annum. We made no payments towards the outstanding notes during the periods presented. The principal balance owing on the notes as of September 30, 2022, and December 31, 2021, was $ 72,466 and $ 72,466 , respectively. No demand for payment has been made. During the nine months ended September 30, 2022, we made repayments to related parties of $ 139,883 and had other noncash reductions of $ 166,747 . There were $ 21,882 and $ 21,882 of short-term advances due to related parties as of September 30, 2022, and December 31, 2021, respectively. The advances are due on demand and included in current liabilities. No demand for payment has been made. We have agreed to issue stock options to Iehab Hawatmeh, our president, as compensation for services provided as our chief executive officer. The terms of his employment agreement require us to grant options to purchase 6,000 shares of our stock each year, with an exercise $ 0.10 . Mr. Hawatmeh held outstanding options to purchase 24,000 and 30,000 shares of common stock as of September 30, 2022, and December 31, 2021, respectively. See Note 12–Stock Options. As of September 30, 2022, and December 31, 2021, we owed our president a total of $ 433,379 and $ 433,379 , respectively, in unsecured advances. The advances and short-term bridge loans were approved by our board of directors under a 5 % borrowing fee. The borrowing fees were waived by our president on these loans. These amounts are included in our liabilities from discontinued operations. As of September 30, 2022, and December 31, 2021, we owed a total of $ 13,740 and $ 13,740 , respectively, to a related party through trade payables incurred in the normal course of business. These amounts are shown as a separate related-party payable on the balance sheet as of each reporting date. During the nine months ended September 30, 2022, we had a net increase in deposits with a related-party inventory supplier totaling $ 185,555 . The related party is an entity controlled by our chief executive officer. All transactions were at a 2 % markup over the related-party’s cost paid for inventory in arm’s-length transactions. Total inventory purchases from the related party were $ 744,709 and $ 845,856 during the nine months ended September 30, 2022 and 2021, respectively. NOTE 6 — OTHER ACCRUED LIABILITIES Accrued tax liabilities consist of delinquent payroll taxes, interest, and penalties owed by us to the Internal Revenue Service (“IRS”) and other tax entities. Accrued liabilities consist of the following: SCHEDULE OF ACCRUED LIABILITIES September 30, 2022 December 31, 2021 Tax liabilities $ 550,126 $ 545,221 Other 1,320,115 793,128 Total $ 1,870,241 $ 1,338,349 Other accrued liabilities as of September 30, 2022, and December 31, 2021, include a non-interest-bearing payable totaling $ 45,000 and $ 45,000 , respectively, that is due on demand and customer deposits totaling $ 1,281,302 and $ 718,535 , respectively. 11 Accrued payroll and compensation liabilities consist of the following: SCHEDULE OF ACCRUED PAYROLL AND COMPENSATION LIABILITIES September 30, 2022 December 31, 2021 Director fees $ 140,000 $ 135,000 Bonus expenses 129,358 121,858 Commissions 2,148 2,148 Consulting 525,322 575,322 Administrative payroll 3,927,197 3,607,070 Total $ 4,724,025 $ 4,441,398 NOTE 7 — COMMITMENTS AND CONTINGENCIES Litigation and Claims Various vendors, service providers, and others have asserted legal claims in previous years. These creditors generally are not actively seeking collection of amounts due to them, and we have determined that the probability of realizing any loss on these claims is remote and will seek to compromise and settle at a deep discount any of such claims that are asserted for collection. These amounts are included in our current liabilities, except where we believe collection or enforcement of the judgments is barred by the applicable statute of limitations, in which case the liabilities have been eliminated. We have not accrued any liability for claims or judgments that we have determined to be barred by the applicable statute of limitations, which generally is eight years for judgments in Utah. Playboy Enterprises, Inc. Our affiliate, Play Beverages, LLC, filed suit against Playboy Enterprises, Inc., in Cook County, Illinois, Circuit Court in October 2012 asserting numerous claims, including breach of contract and tortious interference. Playboy responded with a counterclaim of breach of contract and trademark infringement. After proceedings in October 2016, the court awarded a judgment of $ 6.6 million to Playboy against Play Beverages and CirTran Beverage Corp., our subsidiary. The court denied our motion for a new trial and awarded Playboy treble patent infringement damages and attorney’s fees. We filed a notice of appeal in July 2017 and again in March 2018. Playboy has initiated collection efforts but has recovered no funds. In September 2018, the appellate court affirmed the judgment of the circuit court. We have accrued $ 17,205,599 as of September 30, 2022, and December 31, 2021, related to this judgment, which is included in liabilities in discontinued operations. Delinquent Payroll Taxes, Interest, and Penalties In November 2004, the IRS accepted our amended offer in compromise (the “Offer”) to settle delinquent payroll taxes, interest, and penalties, which required us to pay $ 500,000 , remain current in our payment of taxes for five years , and forego claiming any net operating losses for the years 2001 through 2015 or until we paid taxes on future profits in an amount equal to the taxes of $ 1,455,767 waived by the Offer. In June 2013, we entered into a partial installment agreement to pay $ 768,526 in unpaid 2009 payroll taxes, which required us to pay the IRS 5 % of cash deposits. The monthly payments were to continue until the account balances were paid in full or until the collection statute of limitation expired on October 6, 2020. We are currently in communication with the IRS regarding the statute of limitations on this settlement and appropriate next steps. Amounts of $ 517,684 and $ 525,238 were due as September 30, 2022, and December 31, 2021, respectively. Employment Agreements We engage Iehab Hawatmeh, our president and chief executive officer, through an employment agreement entered in August 2009 and amended in September 2017. In July 2017, Mr. Hawatmeh had resigned all positions with us to pursue other business activities, thereby effectively terminating the agreement. However, the amendment to his employment agreement in September 2017 reinstated Mr. Hawatmeh to his previous positions, with a salary in an amount to be determined. Among other things, the reinstated employment agreement: (a) grants options to purchase a minimum of 6,000 shares of our stock each year, with an exercise price equal to the market price of our common stock as of the grant date, for the maximum term allowed under our stock option plan; (b) provides for health insurance coverage, cell phone, car allowance, life insurance, and director and officer liability insurance, as well as any other bonus approved by our board; and (c) includes additional incentive compensation as follows: (i) a quarterly bonus equal to 5 % of our earnings before interest, taxes, depreciation, and amortization for the applicable quarter; (ii) bonuses equal to 1 % of the net purchase price of any acquisitions we complete that are directly generated and arranged by Mr. Hawatmeh; and (iii) an annual bonus (payable quarterly) equal to 1 % of our gross sales of all products, net of returns and allowances. On January 1, 2020, we resumed accruing wages for our chief executive officer. A total of $ 258,750 was accrued during the nine months ended September 30, 2022. 12 We also have an oral agreement with our other director that requires us to issue options to purchase 2,000 shares of our common stock each year. License Agreements We have entered into agreements requiring us to pay certain royalties for the manufacture and distribution of licensed products. Fees are based on a percentage of sales and remitted quarterly and are included in cost of sales for financial reporting purposes. NOTE 8 — NOTES PAYABLE Notes payable consisted of the following: SCHEDULE OF NOTES PAYABLE September 30, 2022 December 31, 2021 Note payable to former service provider for past due account payable (current) $ 90,000 $ 90,000 Note payable for settlement of debt (long-term) 500,000 500,000 Small Business Administration loan 156,000 156,000 Total $ 746,000 $ 746,000 There was $ 288,192 and $ 252,665 of accrued interest due on these notes as of September 30, 2022, and December 31, 2021, respectively. NOTE 9 — CONVERTIBLE DEBENTURES Convertible debentures consisted of the following: SCHEDULE OF CONVERTIBLE DEBENTURES September 30, 2022 December 31, 2021 Convertible debenture, 5 % stated interest rate, secured by all our assets, due on December 30, 2022 $ 200,000 $ 200,000 Convertible debenture, 5 % stated interest rate, secured by all our assets, due on December 8, 2022 25,000 25,000 Convertible debenture, 5 % stated interest rate, secured by all our assets, due on December 30, 2022 25,000 25,000 Convertible debenture, 5 % stated interest rate, secured by all our assets, due on December 8, 2022 25,000 25,000 Convertible debenture, 5 % stated interest rate, secured by all our assets, due on April 30, 2027 2,390,528 2,390,528 Subtotal $ 2,665,528 $ 2,665,528 Less: discounts ( 456,466 ) ( 524,623 ) Total $ 2,209,062 $ 2,140,905 Less: current portion ( 264,284 ) ( 264,284 ) Long-term portion $ 1,944,778 $ 1,876,621 The convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $ 100 or the lowest bid price for the 20 trading days prior to conversion. During the year ended December 31, 2021, the convertible debenture holder converted $ 6,750 of accrued but unpaid interest into 225,000 shares of our common stock. 13 As of September 30, 2022, and December 31, 2021, we had accrued interest on the convertible debentures totaling $ 1,754,720 and $ 1,655,037 , respectively. NOTE 10 — DERIVATIVE LIABILITIES As discussed in Note 9—Convertible Debentures, we have entered into five separate agreements to borrow a total of $ 2,665,528 with the outstanding principal and interest being convertible at the holder’s option into common stock of the company at the lesser of $ 100 (notes one through four) or $0.10 (note five) or the lowest closing bid price in the prior 20 trading days . Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in our balance sheet. We measure these instruments at their estimated fair value and recognize changes in their estimated fair value in results of operations during the period of change. We have estimated the fair value of these embedded derivatives for convertible debentures using a Monte Carlo simulation as of September 30, 2022, using the following assumptions: SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE Volatility 103.1 % - 116.4 % Risk-free rates 3.74 % - 3.84 % Stock price $ 0.0355 Remaining life 0.25 - 4.58 years The fair values of the derivative instruments are measured each quarter, which resulted in a loss of $ 35,105 and $ 176,746 during the nine months ended September 30, 2022 and 2021, respectively. As of September 30, 2022, and December 31, 2021, the fair market value of the derivatives aggregated $ 973,902 and $ 938,794 , respectively. NOTE 11 – COMMON STOCK TRANSACTIONS We are authorized to issue up to 100,000,000 shares of $ 0.001 par value common stock. During the year ended December 31, 2021, we issued a total of 225,000 shares of common stock for the conversion of $ 6,750 of accrued interest. NOTE 12 — STOCK OPTIONS Stock Incentive Plans During the nine months ended September 30, 2022, and the year ended December 31, 2021, we granted to employees 0 and 8,000 options to purchase shares of common stock, respectively. The 8,000 options granted during the year ended December 31, 2021, were valued using the following assumptions: estimated five -year term, estimated volatility of 91 %, and a risk-free rate of 1.61 %. As of September 30, 2022, and December 31, 2021, we had no unrecognized compensation related to outstanding options that have not yet vested at year-end that would be recognized in subsequent periods. As of September 30, 2022, there were 32,000 options issued and vested with a weighted average exercise price of $ 0.06 and a weighted average remaining life of 2.66 years. Outstanding options as of September 30, 2022, consisted of: SCHEDULE OF STOCK OPTIONS OUTSTANDING Exercise Price Count Average Exercise Remaining Life Exercisable $ 0.01 16,000 0.01 3.60 16,000 $ 0.10 16,000 0.10 1.73 16,000 Total 32,000 0.06 2.66 32,000 14 NOTE 13— DISCONTINUED OPERATIONS At October 21, 2016, we exited the beverage licensing and distribution business. The assets and liabilities associated with this business are displayed as assets and liabilities from discontinued operations as of September 30, 2022, and December 31, 2021. Additionally, the revenues and costs associated with this business are displayed as losses from discontinued operations for the nine months ended September 30, 2022 and 2021. Total assets and liabilities included in discontinued operations were as follows: SCHEDULE OF DISCONTINUED OPERATIONS September 30, 2022 December 31, 2021 Assets from Discontinued Operations: Cash $ — $ — Total assets from discontinued operations $ — $ — Liabilities from Discontinued Operations: Accounts payable $ 18,338,848 $ 18,338,848 Accrued liabilities 589,380 589,380 Accrued interest 1,444,475 1,329,692 Accrued payroll and compensation expense 131,108 131,108 Current maturities of long-term debt 239,085 239,085 Related-party payable 1,776,250 1,776,250 Short-term advances payable 2,784,773 2,784,773 Total liabilities from discontinued operations $ 25,303,919 $ 25,189,136 Net loss from discontinued operations for the nine months ended September 30, 2022 and 2021, were comprised of the following components: Nine Months ended September 30, 2022 2021 Other expense: Interest expense ( 114,784 ) ( 114,784 ) Net loss from discontinued operations $ ( 114,784 ) $ ( 114,784 ) NOTE 14 — SUBSEQUENT EVENTS In accordance with SFAS 165 (ASC 855-10), management has performed an evaluation of subsequent events through the date that the financial statements were issued and has determined that it does not have any material subsequent events to disclose in these consolidated financial statements. On October 19, 2022, the Company renewed its lease with GloBrands, LLC, for 500 square feet of office space in Las Vegas, NV. The lease was renewed on a month to months basis, with monthly payments of $ 2,500 . 15